Biochemical and clinical changes in Wilson's disease heterozygotes
- 10 July 1981
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 7 (1) , 41-45
- https://doi.org/10.1007/bf01805621
Abstract
This paper reports on a study of the heterozygous children of patients with Wilson's disease. A total of 16 children of 10 patients with the disease were followed up. Detailed biochemical, clinical and EEG tests were done. Nearly all the children were found to have reduced serum copper and caeruloplasmin levels and high rates of urine copper excretion following exposure to penicillamine. These findings were different from the results obtained in adult heterozygous carriers. Thirty per cent of the children had pathological neurological findings, and EEG abnormalities were found in 75%.This publication has 10 references indexed in Scilit:
- Changes in total, nondiffusible, and diffusibleplasma zinc and copper during infancyThe Journal of Pediatrics, 1973
- Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).1973
- Lysosomal Defect of Hepatic Copper Excretion in Wilson's Disease (Hepatolenticular Degeneration)Gastroenterology, 1973
- Chronic Hepatitis As a First Manifestation of Wilson's DiseaseAnnals of Internal Medicine, 1972
- Maternal-fetal metabolism of copper and zinc at termAmerican Journal of Obstetrics and Gynecology, 1971
- THE PHYSIOLOGY OF COPPER IN MAN AND ITS RELATION TO WILSON'S DISEASEBrain, 1967
- Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport.1965
- DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE*Journal of Clinical Investigation, 1961
- IMPROVED COLORIMETRIC ENZYMATIC ASSAY OF CERULOPLASMIN1961